| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/06/2023 | 1166.78% | Roth MKM | $6 → $5 | Maintains | Buy |
| 08/29/2023 | 1420.14% | Roth MKM | → $6 | Reiterates | Buy → Buy |
| 07/13/2023 | 102.69% | Goldman Sachs | $2.75 → $0.8 | Maintains | Sell |
| 07/11/2023 | 406.71% | Craig-Hallum | $4 → $2 | Maintains | Buy |
| 06/26/2023 | 406.71% | Jefferies | $5 → $2 | Downgrades | Buy → Hold |
| 05/01/2023 | 596.73% | Goldman Sachs | $3.2 → $2.75 | Maintains | Sell |
| 04/28/2023 | 913.43% | Craig-Hallum | $10 → $4 | Maintains | Buy |
| 04/18/2023 | 710.74% | Goldman Sachs | $3.7 → $3.2 | Maintains | Sell |
| 10/14/2022 | 837.42% | Goldman Sachs | $4.3 → $3.7 | Maintains | Sell |
| 08/16/2022 | 2433.57% | Craig-Hallum | $8 → $10 | Upgrades | Hold → Buy |
| 03/25/2022 | 3193.64% | Jefferies | $16 → $13 | Maintains | Buy |
| 12/22/2021 | 3447% | Canaccord Genuity | $15 → $14 | Maintains | Buy |
| 12/22/2021 | 2433.57% | Craig-Hallum | $14 → $10 | Downgrades | Buy → Hold |
| 06/25/2021 | 4587.1% | Roth Capital | $19 → $18.5 | Maintains | Buy |
| 04/23/2021 | 4207.07% | Canaccord Genuity | $14 → $17 | Maintains | Buy |
| 03/18/2021 | 3447% | Canaccord Genuity | $13 → $14 | Maintains | Buy |
| 12/18/2020 | 2686.93% | JP Morgan | → $11 | Downgrades | Neutral → Underweight |
| 04/17/2020 | — | Jefferies | Upgrades | Hold → Buy | |
| 03/19/2020 | 1166.78% | Goldman Sachs | $7.75 → $5 | Maintains | Sell |
| 03/06/2020 | 2940.28% | Canaccord Genuity | $17 → $12 | Maintains | Buy |
| 12/20/2019 | 3447% | JP Morgan | $15 → $14 | Maintains | Neutral |
| 12/20/2019 | — | First Analysis | Downgrades | Outperform → Neutral | |
| 06/28/2019 | — | Northland Capital Markets | Upgrades | Market Perform → Outperform | |
| 05/29/2019 | 2686.93% | Goldman Sachs | $13 → $11 | Downgrades | Neutral → Sell |
| 03/25/2019 | 4207.07% | JP Morgan | → $17 | Downgrades | Overweight → Neutral |
| 01/25/2019 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 12/21/2018 | 5727.21% | Canaccord Genuity | $25 → $23 | Maintains | Buy |
| 12/11/2018 | 5473.85% | First Analysis | $29 → $22 | Downgrades | Strong Buy → Outperform |
| 10/15/2018 | 5473.85% | Jefferies | → $22 | Initiates Coverage On | → Hold |
What is the target price for CalAmp (CAMP)?
The latest price target for CalAmp (NASDAQ: CAMP) was reported by Roth MKM on October 6, 2023. The analyst firm set a price target for $5.00 expecting CAMP to rise to within 12 months (a possible 1166.78% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CalAmp (CAMP)?
The latest analyst rating for CalAmp (NASDAQ: CAMP) was provided by Roth MKM, and CalAmp maintained their buy rating.
When is the next analyst rating going to be posted or updated for CalAmp (CAMP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CalAmp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CalAmp was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.
Is the Analyst Rating CalAmp (CAMP) correct?
While ratings are subjective and will change, the latest CalAmp (CAMP) rating was a maintained with a price target of $6.00 to $5.00. The current price CalAmp (CAMP) is trading at is $0.39, which is out of the analyst's predicted range.